Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

FX Vollenweider, KH Preller - Nature Reviews Neuroscience, 2020 - nature.com
Renewed interest in the use of psychedelics in the treatment of psychiatric disorders
warrants a better understanding of the neurobiological mechanisms underlying the effects of …

Models of psychedelic drug action: modulation of cortical-subcortical circuits

MK Doss, MB Madden, A Gaddis, MB Nebel… - Brain, 2022 - academic.oup.com
Classic psychedelic drugs such as psilocybin and lysergic acid diethylamide (LSD) have
recaptured the imagination of both science and popular culture, and may have efficacy in …

Serotonin and brain function: a tale of two receptors

RL Carhart-Harris, DJ Nutt - Journal of psychopharmacology, 2017 - journals.sagepub.com
Previous attempts to identify a unified theory of brain serotonin function have largely failed to
achieve consensus. In this present synthesis, we integrate previous perspectives with new …

Pivotal mental states

A Brouwer, RL Carhart-Harris - Journal of …, 2021 - journals.sagepub.com
This paper introduces a new construct, the 'pivotal mental state', which is defined as a hyper-
plastic state aiding rapid and deep learning that can mediate psychological transformation …

[HTML][HTML] Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders

N Singewald, C Schmuckermair, N Whittle… - Pharmacology & …, 2015 - Elsevier
Pathological fear and anxiety are highly debilitating and, despite considerable advances in
psychotherapy and pharmacotherapy they remain insufficiently treated in many patients with …

The role of serotonin 5-HT2A receptors in memory and cognition

G Zhang, RW Stackman Jr - Frontiers in pharmacology, 2015 - frontiersin.org
Serotonin 5-HT2A receptors (5-HT2ARs) are widely distributed in the central nervous
system, especially in brain region essential for learning and cognition. In addition to …

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

AL Halberstadt - Behavioural brain research, 2015 - Elsevier
Abstract Serotonergic hallucinogens, such as (+)-lysergic acid diethylamide, psilocybin, and
mescaline, are somewhat enigmatic substances. Although these drugs are derived from …

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting

L Prochazkova, DP Lippelt, LS Colzato, M Kuchar… - …, 2018 - Springer
Introduction Taking microdoses (a mere fraction of normal doses) of psychedelic
substances, such as truffles, recently gained popularity, as it allegedly has multiple …

Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

R Kraehenmann, KH Preller, M Scheidegger… - Biological …, 2015 - Elsevier
Background The amygdala is a key structure in serotonergic emotion-processing circuits. In
healthy volunteers, acute administration of the serotonin 1A/2A/2C receptor agonist …

Psychedelic drugs in biomedicine

EJ Kyzar, CD Nichols, RR Gainetdinov… - Trends in …, 2017 - cell.com
Psychedelic drugs, such as lysergic acid diethylamide (LSD), mescaline, and psilocybin,
exert profound effects on brain and behavior. After decades of difficulties in studying these …